放射性造影剂肾病：未发现造影剂残留。
Radiocontrast nephropathy: the dye is not cast.
作者信息
Lepor N E
机构信息
Cedars-Sinai Medical Center, Los Angeles, California, USA.
出版信息
Rev Cardiovasc Med. 2000 Summer;1(1):43-54.
PMID:12457151
Abstract
A significant source of morbidity and inhospital mortality following percutaneous coronary intervention is radiocontrast-induced nephropathy. Newer strategies, such as using low-osmolar nonionic contrast agents and selective dopamine agonists, are making it possible to greatly reduce the incidence of postcatheterization nephropathy.
摘要
经皮冠状动脉介入治疗后发病和住院死亡率的一个重要来源是放射性造影剂诱发的肾病。使用低渗非离子型造影剂和选择性多巴胺激动剂等新策略使得大幅降低导管插入术后肾病的发生率成为可能。
Zotero 插件